The constitution of a biological samples bank, attached to epidemiological studies Cohort F-CCSS on iatrogenic effects of treatment of childhood cancer, will identify genetic variants that can modulate the iatrogenic risks of these treatments. The main objective is to provide a biological samples bank to consider, besides the carcinogenic risks, the risk of other iatrogenic diseases in these children, in particular cardiac, cerebrovascular, lung, bone and kidney. These conditions can be very incapacitating and in some cases, fatal. Their impact, however, is poorly estimated as occurring in adulthood, they are rarely made in relation to the treatment received in childhood. The overall project is expected to eventually better define the iatrogenic effects prevention strategies for cancer treatment.
Study Type
OBSERVATIONAL
Enrollment
10,000
Gustave Roussy Cancer Campus Grand Paris
Villejuif, Val de Marne, France
RECRUITINGCentre Léon Bérard
Lyon, France
RECRUITINGInstitut Curie
Paris, France
RECRUITINGStudy of genetic factors who might lead to secondary iatrogenic pathology due to treatment of a childhood cancer
Time frame: From enrollment to the end of study at 15 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.